{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:10:19Z","timestamp":1789071019103,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"DOI":"10.1007\/s00381-026-07457-9","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:45:20Z","timestamp":1789069520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric low-grade glial, glioneuronal and neuronal tumors: a retrospective study of 85 cases"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8112-5807","authenticated-orcid":false,"given":"Meriem","family":"Boubekri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Cherradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"issue":"suppl. 2","key":"7457_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","volume":"22","author":"QT Ostrom","year":"2020","unstructured":"Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2020) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017. Neuro-oncol 22(suppl. 2):iv1\u2013iv96. https:\/\/doi.org\/10.1093\/neuonc\/noaa200","journal-title":"Neuro-oncol"},{"issue":"suppl. 2","key":"7457_CR2","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","volume":"23","author":"QT Ostrom","year":"2021","unstructured":"Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2021) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018. Neuro-oncol 23(suppl. 2):iii1\u2013iii105. https:\/\/doi.org\/10.1093\/neuonc\/noab200","journal-title":"Neuro-oncol"},{"issue":"suppl. 4","key":"7457_CR3","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","volume":"17","author":"QT Ostrom","year":"2015","unstructured":"Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro-oncol 17(suppl. 4):iv1\u2013iv62. https:\/\/doi.org\/10.1093\/neuonc\/nov189","journal-title":"Neuro-oncol"},{"key":"7457_CR4","unstructured":"WHO Classification of Tumours (2021) Central Nervous System Tumours. 5th ed. Lyon: IARC"},{"issue":"1","key":"7457_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-020-00902-z","volume":"8","author":"S Ryall","year":"2020","unstructured":"Ryall S, Tabori Y, Hawkins C (2020) Pediatric low-grade glioma in the era of molecular diagnostics. Acta Neuropathol Commun 8(1):1\u201322. https:\/\/doi.org\/10.1186\/s40478-020-00902-z","journal-title":"Acta Neuropathol Commun"},{"issue":"12","key":"7457_CR6","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/neuonc\/noac188","volume":"24","author":"R Rud\u00e0","year":"2022","unstructured":"Rud\u00e0 R, Capper D, Waldman AD, Pallud J, Minniti G, Kaley TJ et al (2022) EANO - EURACAN - SNO guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors. Neuro-oncol 24(12):2015\u20132034. https:\/\/doi.org\/10.1093\/neuonc\/noac188","journal-title":"Neuro-oncol"},{"issue":"8","key":"7457_CR7","doi-asserted-by":"publisher","first-page":"e27063","DOI":"10.1002\/pbc.27063","volume":"65","author":"ZS Sadighi","year":"2018","unstructured":"Sadighi ZS, Curtis E, Zabrowksi J, Billups C, Gajjar A, Khan R, Qaddoumi I (2018) Neurologic impairments from pediatric low-grade glioma by tumor location and timing of diagnosis. Pediatr Blood Cancer 65(8):e27063. https:\/\/doi.org\/10.1002\/pbc.27063","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"7457_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ccell.2020.03.011","volume":"37","author":"S Ryall","year":"2020","unstructured":"Ryall S, Zapotocky M, Fukuoka K, Nobre L et al (2020) Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas. Cancer Cell 37(4):569-583.e5. https:\/\/doi.org\/10.1016\/j.ccell.2020.03.011","journal-title":"Cancer Cell"},{"issue":"9","key":"7457_CR9","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00381-015-2800-9","volume":"31","author":"M Garz\u00f3n","year":"2015","unstructured":"Garz\u00f3n M, Garc\u00eda-Fructuoso G, Su\u00f1ol M, Mora J, Cruz O (2015) Low-grade gliomas in children: single institutional experience in 198 cases. Childs Nerv Syst 31(9):1447\u20131459. https:\/\/doi.org\/10.1007\/s00381-015-2800-9","journal-title":"Childs Nerv Syst"},{"issue":"10","key":"7457_CR10","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.ejca.2011.12.013","volume":"48","author":"E Crocetti","year":"2012","unstructured":"Crocetti E, Trama A, Stiller C, Caldarella A et al (2012) Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer 48(10):1532\u20131542. https:\/\/doi.org\/10.1016\/j.ejca.2011.12.013","journal-title":"Eur J Cancer"},{"issue":"5","key":"7457_CR11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1158\/1055-9965.EPI-20-1443","volume":"30","author":"MA Fahmideh","year":"2021","unstructured":"Fahmideh MA, Scheurer ME (2021) Pediatric brain tumors: descriptive epidemiology, risk factors, and future directions. Cancer Epidemiol Biomarkers Prev 30(5):813\u2013821. https:\/\/doi.org\/10.1158\/1055-9965.EPI-20-1443","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"7457_CR12","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00381-010-1126-x","volume":"26","author":"K Makino","year":"2010","unstructured":"Makino K, Nakamura H, Yano S et al (2010) Population-based epidemiological study of primary intracranial tumors in childhood. Childs Nerv Syst 26(8):1029\u20131034. https:\/\/doi.org\/10.1007\/s00381-010-1126-x","journal-title":"Childs Nerv Syst"},{"issue":"suppl. 4","key":"7457_CR13","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Gittleman H, Liao P et al (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro-oncol 16(suppl. 4):iv1-63. https:\/\/doi.org\/10.1093\/neuonc\/nou223","journal-title":"Neuro-oncol"},{"issue":"7","key":"7457_CR14","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/pbc.24958","volume":"61","author":"P Bandopadhayay","year":"2014","unstructured":"Bandopadhayay P, Bergthold G, London WB et al (2014) Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database. Pediatr Blood Cancer 61(7):1173\u20131179. https:\/\/doi.org\/10.1002\/pbc.24958","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"7457_CR15","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/neuonc\/nos202","volume":"14","author":"AK Gnekow","year":"2012","unstructured":"Gnekow AK, Falkenstein F, von Hornstein S et al (2012) Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology. Neuro-oncol 14(10):1265\u20131284. https:\/\/doi.org\/10.1093\/neuonc\/nos202","journal-title":"Neuro-oncol"},{"issue":"2","key":"7457_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.anpedi.2014.02.009","volume":"82","author":"MJ Pardal Souto","year":"2015","unstructured":"Pardal Souto MJ, Hern\u00e1ndez Marqu\u00e9s C, Lassaletta Atienza A (2015) Low-grade gliomas: review of 10 years. An Pediatr 82(2):68\u201374. https:\/\/doi.org\/10.1016\/j.anpedi.2014.02.009","journal-title":"An Pediatr"},{"issue":"4","key":"7457_CR17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1177\/0883073815599259","volume":"31","author":"A Chalil","year":"2016","unstructured":"Chalil A, Ramaswamy V (2016) Low grade gliomas in children. J Child Neurol 31(4):517\u2013522. https:\/\/doi.org\/10.1177\/0883073815599259","journal-title":"J Child Neurol"},{"issue":"11","key":"7457_CR18","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1177\/0883073809342005","volume":"24","author":"AJ Sievert","year":"2009","unstructured":"Sievert AJ, Fisher MJ (2009) Pediatric low-grade gliomas. J Child Neurol 24(11):1397\u20131408. https:\/\/doi.org\/10.1177\/0883073809342005","journal-title":"J Child Neurol"},{"issue":"6","key":"7457_CR19","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/neuonc\/now209","volume":"19","author":"RJ Packer","year":"2017","unstructured":"Packer RJ, Pfister S, Bouffet E et al (2017) Pediatric low-grade gliomas: implications of the biologic era. Neuro-oncol 19(6):750\u2013761. https:\/\/doi.org\/10.1093\/neuonc\/now209","journal-title":"Neuro-oncol"},{"issue":"3","key":"7457_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1055\/a-0889-8256","volume":"231","author":"AK Gnekow","year":"2019","unstructured":"Gnekow AK, Kandels D, Tilburg CV et al (2019) SIOP-E-BTG and GPOH guidelines for diagnosis and treatment of children and adolescents with low grade glioma. Klin Padiatr 231(3):107\u2013135. https:\/\/doi.org\/10.1055\/a-0889-8256","journal-title":"Klin Padiatr"},{"issue":"1","key":"7457_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40644-014-0035-8","volume":"14","author":"JA Guzm\u00e1n-De-Villoria","year":"2014","unstructured":"Guzm\u00e1n-De-Villoria JA, Mateos-P\u00e9rez JM, Fern\u00e1ndez-Garc\u00eda P, Castro E, Desco M (2014) Added value of advanced over conventional magnetic resonance imaging in grading gliomas and other primary brain tumors. Cancer Imaging 14(1):35. https:\/\/doi.org\/10.1186\/s40644-014-0035-8","journal-title":"Cancer Imaging"},{"issue":"6","key":"7457_CR22","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/jmri.26012","volume":"48","author":"MZ Goryawala","year":"2018","unstructured":"Goryawala MZ, Heros DO, Komotar RJ, Sheriff S, Saraf-Lavi E, Maudsley AA (2018) Value of diffusion kurtosis imaging in assessing low-grade gliomas. J Magn Reson Imaging 48(6):1551\u20131558. https:\/\/doi.org\/10.1002\/jmri.26012","journal-title":"J Magn Reson Imaging"},{"key":"7457_CR23","doi-asserted-by":"publisher","first-page":"100159","DOI":"10.1016\/j.wnsx.2023.100159","volume":"18","author":"A Agarwal","year":"2023","unstructured":"Agarwal A, Kanekar S, Sabat S, Bathla G (2023) Value of quantitative apparent diffusion coefficients in differentiating low-grade gliomas from mixed neuronal-glial tumors. World Neurosurg X 18:100159. https:\/\/doi.org\/10.1016\/j.wnsx.2023.100159","journal-title":"World Neurosurg X"},{"key":"7457_CR24","doi-asserted-by":"publisher","first-page":"153821","DOI":"10.1016\/j.prp.2022.153821","volume":"232","author":"D Salles","year":"2022","unstructured":"Salles D, Santino SF, Ribeiro DA, Malinverni ACM, St\u00e1vale JN (2022) The involvement of the MAPK pathway in pilocytic astrocytomas. Pathol Res Pract 232:153821. https:\/\/doi.org\/10.1016\/j.prp.2022.153821","journal-title":"Pathol Res Pract"},{"issue":"6","key":"7457_CR25","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/ng.2611","volume":"45","author":"J Zhang","year":"2013","unstructured":"Zhang J, Wu G, Miller CP et al (2013) Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet 45(6):602\u2013612. https:\/\/doi.org\/10.1038\/ng.2611","journal-title":"Nat Genet"},{"issue":"1","key":"7457_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40478-018-0551-z","volume":"6","author":"M Pekmezci","year":"2018","unstructured":"Pekmezci M, Villanueva-Meyer JE, Goode B et al (2018) The genetic landscape of ganglioglioma. Acta Neuropathol Commun 6(1):47. https:\/\/doi.org\/10.1186\/s40478-018-0551-z","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"7457_CR27","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00401-016-1539-z","volume":"131","author":"I Qaddoumi","year":"2016","unstructured":"Qaddoumi I, Orisme W, Wen J et al (2016) Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Acta Neuropathol 131(6):833\u2013845. https:\/\/doi.org\/10.1007\/s00401-016-1539-z","journal-title":"Acta Neuropathol"},{"issue":"1","key":"7457_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/MOP.0000000000000717","volume":"31","author":"P de Blank","year":"2019","unstructured":"de Blank P, Bandopadhayay P, Haas-Kogan D, Fouladi M, Fangusaro J (2019) Management of pediatric low-grade glioma. Curr Opin Pediatr 31(1):21\u201327. https:\/\/doi.org\/10.1097\/MOP.0000000000000717","journal-title":"Curr Opin Pediatr"},{"key":"7457_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000467140","volume":"31","author":"RD Kortmann","year":"2018","unstructured":"Kortmann RD, Seidel C, M\u00fcller K, Hirsch FW (2018) Irradiation of intracranial gliomas in children. Prog Neurol Surg 31:87\u2013101. https:\/\/doi.org\/10.1159\/000467140","journal-title":"Prog Neurol Surg"},{"issue":"1","key":"7457_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/nop\/npz033","volume":"7","author":"T Cooney","year":"2020","unstructured":"Cooney T, Yeo KK, Kline C, Prados M, Haas-Kogan D, Chi S, Mueller S (2020) Neuro-oncology practice clinical debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma. Neuro-oncol Pract 7(1):4\u201310. https:\/\/doi.org\/10.1093\/nop\/npz033","journal-title":"Neuro-oncol Pract"},{"issue":"10","key":"7457_CR31","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/neuonc\/noab047","volume":"23","author":"J Fangusaro","year":"2021","unstructured":"Fangusaro J, Onar-Thomas A, Poussaint TY et al (2021) A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study. Neuro-oncol 23(10):1777\u20131788. https:\/\/doi.org\/10.1093\/neuonc\/noab047","journal-title":"Neuro-oncol"},{"issue":"7","key":"7457_CR32","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S1470-2045(19)30277-3","volume":"20","author":"J Fangusaro","year":"2019","unstructured":"Fangusaro J, Onar-Thomas A, Poussaint TY et al (2019) Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. Lancet Oncol 20(7):1011\u20131022. https:\/\/doi.org\/10.1016\/S1470-2045(19)30277-3","journal-title":"Lancet Oncol"},{"issue":"24","key":"7457_CR33","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.1158\/1078-0432.CCR-19-2177","volume":"25","author":"DR Hargrave","year":"2019","unstructured":"Hargrave DR, Bouffet E, Tabori U et al (2019) Efficacy and safety of dabrafenib in pediatric patients with BRAF V600 mutation-positive relapsed or refractory low-grade glioma: results from a phase I\/IIa study. Clin Cancer Res 25(24):7303\u20137311. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2177","journal-title":"Clin Cancer Res"},{"issue":"3","key":"7457_CR34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11060-020-03640-3","volume":"149","author":"F Selt","year":"2020","unstructured":"Selt F, van Tilburg CM, Bison B et al (2020) Response to trametinib treatment in progressive pediatric low-grade glioma patients. J Neurooncol 149(3):499\u2013510. https:\/\/doi.org\/10.1007\/s11060-020-03640-3","journal-title":"J Neurooncol"},{"issue":"10","key":"7457_CR35","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1093\/neuonc\/noaa071","volume":"22","author":"NJ Ullrich","year":"2020","unstructured":"Ullrich NJ, Prabhu SP, Reddy AT et al (2020) A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study. Neuro-oncol 22(10):1527\u20131535. https:\/\/doi.org\/10.1093\/neuonc\/noaa071","journal-title":"Neuro-oncol"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-026-07457-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-026-07457-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-026-07457-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:45:23Z","timestamp":1789069523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-026-07457-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7457"],"URL":"https:\/\/doi.org\/10.1007\/s00381-026-07457-9","relation":{},"ISSN":["1433-0350"],"issn-type":[{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was waived by the local Ethics Committee of the Faculty of Medicine and Pharmacy at Mohammed V University in Rabat in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"358"}}